Is a difference of 1-2 cycles in Ct values between different batches of qPCR reagents normal?

I have encountered batch-to-batch differences of 1.5-2 cycles. The manufacturer says this is normal and it cannot be completely dismissed. A slope change from -3.2 to -3.5 indicates that the amplification efficiency drops from about 105% to about 93%. This shift may be acceptable for research, but it is indeed troublesome for cutoff determination. It is recommended not to directly carry over the old cutoff. First, use negative controls, weak positive standards, and samples near the cutoff to perform validation of the new batch. If necessary, reset the decision threshold or add a gray zone. At the same time, ask the manufacturer to provide the COA and batch-to-batch consistency data for this batch to see what Ct shift their internal control allows, and then judge in combination with your own project requirements.

Don't rush to blame the reagent lot entirely. It is recommended that on the same day, using the same plate, the same primers and probes, and the same template conditions, you perform parallel gradient dilution comparisons between the old and new lots of master mix to rule out primer and probe degradation, repeated freeze-thaw cycles of the template, nucleic acid extraction reagent lot, pipette calibration, and differences in qPCR instrument optics and consumable lots. In particular, different lots of PCR tubes or sealing films can sometimes also cause an overall Ct shift. If the old and new lots still differ by 1.5–2 on the same plate, it can basically be confirmed to be a reagent lot issue; keeping a small amount of the old lot for bridging can help determine whether the new lot is acceptable.

For lot-to-lot consistency, prioritize international brands such as Thermo TaqMan Universal Master Mix II with UNG, Takara Probe qPCR Mix, and Bio-Rad SsoAdvanced Universal Probes Supermix, which have a more stable reputation but are more expensive; among domestic options, look for manufacturers with ISO13485/IVD backgrounds such as Vazyme, TransGen, and Yeasen, and request lot-to-lot consistency validation reports. The key is not only the brand, but whether lot-to-lot Ct shift and amplification efficiency are used as release indicators. For a monthly usage of 500-800 reactions, it is recommended to purchase a single large package of the same lot number at one time to reduce the frequency of lot changes.

It is recommended to manage qPCR reagent lot numbers as a key change control. Before switching lots, perform a simplified verification: standard curve slope/efficiency, weak positive Ct SD, and whether NTC shows amplification; set acceptance criteria such as weak positive Ct shift ≤1.0 and slope between -3.1 and -3.6. For samples near the cutoff, add replicate wells or establish a gray zone, and if necessary, confirm with digital PCR. When signing agreements with suppliers, it is advisable to stipulate replacement or compensation for out-of-specification results. For a usage of 500–800 reactions/month, you may request that the distributor provide small samples of the new lot in advance for bridging to avoid being forced into a passive position by directly purchasing large quantities of a new lot.